151 related articles for article (PubMed ID: 33317217)
1. In Vivo Evaluation of a Miniaturized Fluorescence Molecular Tomography (FMT) Endoscope for Breast Cancer Detection Using Targeted Nanoprobes.
Yang H; Qian W; Yang L; Xie H; Jiang H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317217
[TBL] [Abstract][Full Text] [Related]
2. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging.
Tan Y; Cao Z; Sajja HK; Lipowska M; Wang YA; Yang L; Jiang H
J Xray Sci Technol; 2013; 21(1):43-52. PubMed ID: 23507851
[TBL] [Abstract][Full Text] [Related]
3. Optical molecular imaging-guided radiation therapy part 2: Integrated x-ray and fluorescence molecular tomography.
Shi J; Udayakumar TS; Wang Z; Dogan N; Pollack A; Yang Y
Med Phys; 2017 Sep; 44(9):4795-4803. PubMed ID: 28626876
[TBL] [Abstract][Full Text] [Related]
4. Miniature fluorescence molecular tomography (FMT) endoscope based on a MEMS scanning mirror and an optical fiberscope.
Yang H; Wang D; Shan T; Dai X; Xie H; Yang L; Jiang H
Phys Med Biol; 2019 Jun; 64(12):125015. PubMed ID: 31117059
[TBL] [Abstract][Full Text] [Related]
5. Shortwave infrared emitting multicolored nanoprobes for biomarker-specific cancer imaging in vivo.
Kantamneni H; Barkund S; Donzanti M; Martin D; Zhao X; He S; Riman RE; Tan MC; Pierce MC; Roth CM; Ganapathy V; Moghe PV
BMC Cancer; 2020 Nov; 20(1):1082. PubMed ID: 33172421
[TBL] [Abstract][Full Text] [Related]
6. Receptor-targeted nanoparticles for in vivo imaging of breast cancer.
Yang L; Peng XH; Wang YA; Wang X; Cao Z; Ni C; Karna P; Zhang X; Wood WC; Gao X; Nie S; Mao H
Clin Cancer Res; 2009 Jul; 15(14):4722-32. PubMed ID: 19584158
[TBL] [Abstract][Full Text] [Related]
7. uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
Yang L; Sajja HK; Cao Z; Qian W; Bender L; Marcus AI; Lipowska M; Wood WC; Wang YA
Theranostics; 2013; 4(1):106-18. PubMed ID: 24396518
[TBL] [Abstract][Full Text] [Related]
8. HER-2/neu targeted delivery of a nanoprobe enables dual photoacoustic and fluorescence tomography of ovarian cancer.
Xi L; Satpathy M; Zhao Q; Qian W; Yang L; Jiang H
Nanomedicine; 2014 Apr; 10(3):669-77. PubMed ID: 24269306
[TBL] [Abstract][Full Text] [Related]
9. Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic iron oxide nanoparticles as contrast agents.
Xi L; Grobmyer SR; Zhou G; Qian W; Yang L; Jiang H
J Biophotonics; 2014 Jun; 7(6):401-9. PubMed ID: 23125139
[TBL] [Abstract][Full Text] [Related]
10. Intracranial glioma xenograft model rapidly reestablishes blood-brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents.
Habimana-Griffin L; Ye D; Carpenter J; Prior J; Sudlow G; Marsala L; Mixdorf M; Rubin J; Chen H; Achilefu S
J Biomed Opt; 2020 Feb; 25(2):1-13. PubMed ID: 32112540
[TBL] [Abstract][Full Text] [Related]
11. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
[TBL] [Abstract][Full Text] [Related]
12. Near-Infrared Fluorescent and Magnetic Resonance Dual-Imaging Coacervate Nanoprobes for Trypsin Mapping and Targeted Payload Delivery of Malignant Tumors.
Guo H; Song S; Dai T; Sun K; Zhou G; Li M; Mann S; Dou H
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17302-17313. PubMed ID: 32212678
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.
Yang L; Mao H; Cao Z; Wang YA; Peng X; Wang X; Sajja HK; Wang L; Duan H; Ni C; Staley CA; Wood WC; Gao X; Nie S
Gastroenterology; 2009 May; 136(5):1514-25.e2. PubMed ID: 19208341
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent activatable gadofullerene nanoprobes as NIR-MR dual-modal in vivo imaging contrast agent.
Li C; Huang H; Cui R; Li J; Guo X; Yao H; Liu B; Xu B; Li Y; Liu S; Dong J; Xing G; Sun B
Colloids Surf B Biointerfaces; 2018 Nov; 171():159-166. PubMed ID: 30029098
[TBL] [Abstract][Full Text] [Related]
15. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.
Miller-Kleinhenz J; Guo X; Qian W; Zhou H; Bozeman EN; Zhu L; Ji X; Wang YA; Styblo T; O'Regan R; Mao H; Yang L
Biomaterials; 2018 Jan; 152():47-62. PubMed ID: 29107218
[TBL] [Abstract][Full Text] [Related]
16. Detection of brain tumors using fluorescence diffuse optical tomography and nanoparticles as contrast agents.
Fortin PY; Genevois C; Koenig A; Heinrich E; Texier I; Couillaud F
J Biomed Opt; 2012 Dec; 17(12):126004. PubMed ID: 23208215
[TBL] [Abstract][Full Text] [Related]
17. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery.
Kurbegovic S; Juhl K; Chen H; Qu C; Ding B; Leth JM; Drzewiecki KT; Kjaer A; Cheng Z
Bioconjug Chem; 2018 Nov; 29(11):3833-3840. PubMed ID: 30296054
[TBL] [Abstract][Full Text] [Related]
18. Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography.
Gremse F; Theek B; Kunjachan S; Lederle W; Pardo A; Barth S; Lammers T; Naumann U; Kiessling F
Theranostics; 2014; 4(10):960-71. PubMed ID: 25157277
[TBL] [Abstract][Full Text] [Related]
19. Multimodal near-infrared-emitting PluS Silica nanoparticles with fluorescent, photoacoustic, and photothermal capabilities.
Biffi S; Petrizza L; Garrovo C; Rampazzo E; Andolfi L; Giustetto P; Nikolov I; Kurdi G; Danailov MB; Zauli G; Secchiero P; Prodi L
Int J Nanomedicine; 2016; 11():4865-4874. PubMed ID: 27703352
[TBL] [Abstract][Full Text] [Related]
20. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
